|
| Events
5th International Conference and Exhibition on Pharmaceutical Science and Technology
June 21-23, 2022
Bangkok, Thailand
Invited lecture:
Lipid-based Nanocarriers for Oral Delivery of Therapeutic Peptides: Hype or Hope?
Prof. Dr. A. Bernkop-Schnürch
more...
13th Global Drug Delivery & Formulation Summit
June 27-29, 2022
Berlin, Germany
Invited lecture:
Novel Nanotechnologies for Mucosal Delivery of Small Molecules and Biologics: Old Problems but New Solutions
Prof. Dr. A. Bernkop-Schnürch
more...
|
|
 Disintegration behaviour of
tablets based on polycarbophil (PCP) and sodium carboxymethyl-cellulose (CMC) (grey bars) and of the corresponding thiolated polymers (blue bars) [Bernkop-Schnürch, A., Scholler, S., and Biebel, R.G. (2000). Development of controlled drug release systems based on polymer-cysteine conjugates. J. Cont. Rel, 66, 39].
Release profile of
fluoresein from tablets based on poly(acrylic acid) (grey graph) and from tablets based on thiolated poly(acrylic acid) (blue graph) [Hornof, M.D., Weyenberg, W., Ludwig, A., and Bernkop– Schnürch, A. (2003). A mucoadhesive ocular insert: Development and in vivo evaluation in humans. J. Cont. Rel. 89, 419].
|
|
Controlled Drug Release
Due to a sustained drug
release, a prolonged therapeutic level of drugs exhibiting a short
elimination half-live can be maintained. Consequently the frequency of
dosing can be reduced contributing to an improved compliance. The release of
drugs out of polymeric carrier systems can be controlled by a simple
diffusion process. So far the efficacy of such delivery systems, however,
was limited by a too rapid disintegration and/or erosion of the polymeric
network [Bernkop-Schnürch, A., Scholler, S., and Biebel, R.G. (2000). Development of controlled drug release systems based on polymer-cysteine conjugates. J. Control. Release, 66, 39; Clausen, A.E., and Bernkop-Schnürch, A. (2001) Development and in vitro evaluation of a peptide drug delivery system based on thiolated polycarbophil. Pharm. Ind., 63, 312]. By using thiolated polymers this essential shortcoming can be
overcome. Because of the formation of inter- and intrachain disulfide bonds
during the swelling process, the stability of the polymeric drug carrier
matrix is strongly improved. Hence, a controlled drug release for numerous
hours is guaranteed. This controlled drug release has also been demonstrated
by studies in human volunteers.
|
|
News
A. Bernkop-Schnürch, CSO ThioMatrix, was honored with the Gattefossé North America Award 2017
more....
|
|
ThioMatrix Hotline:
+43 512 890046
Mo-Th 9.00-17.00
and Fr 9.00-14.00
Print this page
|
Download references about thiomers
|
|
